Literature DB >> 363301

The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man.

M Reivich, D Kuhl, A Wolf, J Greenberg, M Phelps, T Ido, V Casella, J Fowler, E Hoffman, A Alavi, P Som, L Sokoloff.   

Abstract

A method has been developed to measure local glucose consumption in the various structures of the brain in man with three-dimensional resolution. [18F]-2-deoxy-2-fluoro-D-glucose is used as a tracer for the exchange of glucose between plasma and brain and its phosphorylation by hexokinase in the tissue. A mathematical model and derived operational equation are used which enable local cerebral glucose consumption to be calculated in terms of the following measurable variables. An intravenous bolus of [18F]-2-deoxy-2-fluoro-D-glucose is given and the arterial specific activity monitored for a predetermined period of from 30 to 120 minutes. Starting at 30 minutes, the activity in a series of sections through the brain is determined with three-dimensional resolution by an emission tomographic scanner. The method was used to measure local cerebral glucose consumption in two normal volunteers. The values in gray matter structures range from 5.79 mg/100 g per minute in the cerebellar cortex to 10.27 in the visual cortex, whereas, in white matter structures, the values range from 3.64 mg/100 g per minute in the corpus callosum to 4.22 in the occipital lobe. Average values for gray matter, white matter, and whole brain metabolic rates, calculated as a weighted average based on the approximate volume of each structure, are 8.05, 3.80, and 5.90 mg/100 g per minute, respectively. The value of 5.9 mg/100 g per minute compares favorably with values previously reported.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 363301     DOI: 10.1161/01.res.44.1.127

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  169 in total

Review 1.  Positron emission tomography (PET) in the evaluation of patients with cancer.

Authors:  H A Godwin; J H Zuger
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

Review 2.  Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.

Authors:  Ernesto Solis; Kevin N Hascup; Erin R Hascup
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Hemodynamic changes after occlusion of the posterior superior sagittal sinus: an experimental PET study in cats.

Authors:  Bernhard Schaller; Rudolf Graf; Yasuhiro Sanada; Markus Tolnay; Gerhard Rosner; Klaus Wienhard; Wolf-Dieter Heiss
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

Review 4.  Measuring response to chemotherapy in locally advanced breast cancer: methodological considerations.

Authors:  Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-22       Impact factor: 9.236

Review 5.  Stable isotope-resolved metabolomics and applications for drug development.

Authors:  Teresa W-M Fan; Pawel K Lorkiewicz; Katherine Sellers; Hunter N B Moseley; Richard M Higashi; Andrew N Lane
Journal:  Pharmacol Ther       Date:  2011-12-23       Impact factor: 12.310

Review 6.  History of International Society for Cerebral Blood Flow and Metabolism.

Authors:  Olaf B Paulson; Iwao Kanno; Martin Reivich; Louis Sokoloff
Journal:  J Cereb Blood Flow Metab       Date:  2011-12-21       Impact factor: 6.200

Review 7.  Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives.

Authors:  Harald Hampel; Richard Frank; Karl Broich; Stefan J Teipel; Russell G Katz; John Hardy; Karl Herholz; Arun L W Bokde; Frank Jessen; Yvonne C Hoessler; Wendy R Sanhai; Henrik Zetterberg; Janet Woodcock; Kaj Blennow
Journal:  Nat Rev Drug Discov       Date:  2010-07       Impact factor: 84.694

8.  MR-based molecular imaging of the brain: the next frontier.

Authors:  M E de Backer; R J A Nabuurs; M A van Buchem; L van der Weerd
Journal:  AJNR Am J Neuroradiol       Date:  2010-09-23       Impact factor: 3.825

9.  Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer.

Authors:  Savannah C Partridge; Risa K Vanantwerp; Robert K Doot; Xiaoyu Chai; Brenda F Kurland; Peter R Eby; Jennifer M Specht; Lisa K Dunnwald; Erin K Schubert; Constance D Lehman; David A Mankoff
Journal:  J Magn Reson Imaging       Date:  2010-11       Impact factor: 4.813

10.  Experimental studies on myocardial glucose metabolism of rats with 18F-2-fluoro-2-deoxy-D-glucose.

Authors:  K Yamada; S Endo; H Fukuda; Y Abe; S Yoshioka; M Itoh; K Kubota; J Hatazawa; T Satoh; T Matsuzawa
Journal:  Eur J Nucl Med       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.